Turning hard science into raised capital and credible structure
Strategic advisory for biotechnology and life-science companies, investors and mission-driven organizations navigating capital formation, governance and growth
Areas of expertise
-
MAV supports capital raises from preparation through investor engagement, building the infrastructure required to run a credible and disciplined process.
Work includes investor positioning, pitch materials, business plans, financial presentation, data-room preparation, cap-table review, investor pipelines, outreach strategy and ongoing investor communications.
The objective is not simply to produce materials. It is to create a fundraising process that is organized, defensible and ready for sophisticated scrutiny.
For founders and leadership teams preparing to raise institutional or strategic capital.
-
MAV advises on the composition, structure and formation of commercial boards and scientific advisory boards.
Work spans candidate mapping and assessment, role definition, governance structure, biographies and board materials, agreements, onboarding and ongoing board architecture.
In biotechnology and life sciences, the people around a company communicate something before the company says a word. A well-constructed board can strengthen scientific credibility, commercial judgment and investor confidence.
For organizations building the leadership and advisory infrastructure required for their next stage of growth.
-
MAV advises organizations building more complex commercial, research and philanthropic structures.
Experience includes work across nonprofit and commercial entities, governance frameworks, charters, organizational design and the disciplines required to maintain clarity between mission-driven and commercial activity.
The focus is practical: ensuring each entity has a clear purpose, appropriate governance and the structural discipline required to support long-term growth.
For science-led organizations expanding beyond a single commercial structure.
-
MAV advises investors and holders of private biotechnology and life-science positions on market intelligence, timing and strategic positioning.
The work includes assessing market appetite, mapping relevant participants, identifying potential counterparties and developing an approach strategy before a transaction is pursued.
Where appropriate, MAV may also facilitate relevant introductions. MAV does not execute securities transactions or act as a broker; transactions are conducted directly by principals and their appointed advisers.
For investors and private shareholders seeking a clearer view of the market before they act.
-
MAV works with scientific institutes, foundations and mission-driven organizations seeking to build serious philanthropic funding programs.
Advisory spans major-gift strategy, donor segmentation, pipeline development, case-for-support positioning, cultivation programs and events designed as part of a broader fundraising strategy.
The objective is to build a repeatable philanthropic engine rather than a series of isolated fundraising moments.
For science-led nonprofits and institutions seeking sustained support from families, foundations and major donors.
-
Complex science only creates value if the people making decisions can understand why it matters.
MAV develops the strategic narratives and materials used to communicate scientific and commercial opportunity to investors, boards, donors and other sophisticated stakeholders.
This includes investor positioning, board materials, executive messaging, strategic presentations and the translation of technical information into clear, decision-ready communication.
For leadership teams that need to communicate complexity without losing its substance.
Turning scientific ambition into institutional readiness
MAV Advisors works with biotechnology and life-science organizations at the point where scientific ambition needs equally rigorous commercial infrastructure.
That may mean preparing a company for capital, building a board that strengthens credibility, establishing the governance around a new entity, developing a serious philanthropic program, or translating complex science into a narrative that investors, directors and donors can act on.
MAV also advises investors and holders of private life-science positions who need a clearer view of the market before they move.
The work sits across science, capital and organizational structure: helping clients make complex decisions, communicate opportunity clearly and build the infrastructure required for what comes next.
Start a conversation
MAV works with biotechnology and life-science companies, investors and mission-driven organizations navigating capital, governance and strategic growth.
If you're preparing for a raise, strengthening governance, building a new organizational structure, developing a philanthropic strategy or assessing a private-market position, get in touch.